Showing results (21-30 of 3,889) with videos related to

Sort By:
Pageof 389
European Journal of Pharmacology|November 5, 1997
SR141716A is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, T H Burkey, P Consroe, et al.
The International Journal of Neuroscience|January 1, 1988
Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patientR P Iacono, J Linford, R Sandyk, et al.
Life Sciences|March 13, 1998
AM630 is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, A Makriyannis, H Deng, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1991
Controlled clinical trial of cannabidiol in Huntington's diseaseP Consroe, J Laguna, J Allender, et al.
European Journal of Pharmacology|February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brainY Hosohata, R M Quock, K Hosohata, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Neuroreport|January 31, 1996
Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociceptionS A Edsall, R J Knapp, T W Vanderah, et al.
Experientia|September 15, 1988
Enantiomeric cannabinoids: stereospecificity of psychotropic activityR Mechoulam, J J Feigenbaum, N Lander, et al.
NIDA Research Monograph|January 1, 1987
Structure-anticonvulsant activity relationships of cannabidiol analogsA R Martin, P Consroe, V V Kane, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1995
Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in miceP Consroe, N B Egen, F E Russell, et al.
Pageof 389